Skip to main content
SpringerLink
Log in

Re-irradiation in lung cancer

  • Review
  • Published:
Journal of Radiation Oncology

Abstract

Local-regional control is an important component of care for patients treated for lung cancer. Local-regional disease progression can lead directly to problems including pain, dysphagia, hemoptysis, cough, dyspnea, superior vena cava syndrome, and death. Local-regional failure remains common despite advances in radiation therapy, chemotherapy, and surgery. For patients and caregivers, local-regional failure management poses a dilemma for balancing safety and efficacy. Multiple strategies for local-regional failure management exist. This report examines data from the use of external beam radiation therapy, stereotactic body radiotherapy, and endobronchial brachytherapy for management of local-regional failure in lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29

    Article  PubMed  Google Scholar 

  2. Baumann P, Nyman J, Hoyer M et al (2009) Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol Off J Am Soc Clin Oncol 27:3290–3296

    Article  Google Scholar 

  3. Onishi H, Shirato H, Nagata Y et al (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 2:S94–S100

    Google Scholar 

  4. Timmerman R, Paulus R, Galvin J et al (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA J Am Med Assoc 303:1070–1076

    Article  CAS  Google Scholar 

  5. Albain KS, Swann RS, Rusch VW et al (2009) Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 374:379–386

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Bradley JD, Bae K, Graham MV et al (2010) Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. J Clin Oncol Off J Am Soc Clin Oncol 28:2475–2480

    Article  Google Scholar 

  7. Machtay M, Bae K, Movsas B et al (2012) Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 82:425–434

    Article  PubMed  Google Scholar 

  8. Machtay M, Paulus R, Moughan J et al (2012) Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 7:716–722

    Google Scholar 

  9. Le Chevalier T, Arriagada R, Quoix E et al (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417–423

    Article  PubMed  Google Scholar 

  10. Cheng S, Evans WK, Stys-Norman D, Shepherd FA (2007) Lung Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 2:348–354

    Google Scholar 

  11. Noble J, Ellis PM, Mackay JA, Evans WK (2006) Lung Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 1:1042–1058

    CAS  Google Scholar 

  12. Jeremic B, Videtic GM (2011) Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer: a review. Int J Radiat Oncol Biol Phys 80:969–977

    Article  PubMed  Google Scholar 

  13. Wu KL, Jiang GL, Qian H et al (2003) Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial. Int J Radiat Oncol Biol Phys 57:1345–1350

    Article  PubMed  Google Scholar 

  14. Griffioen GH, Dahele M, de Haan PF, van de Ven PM, Slotman BJ, Senan S (2014) High-dose, conventionally fractionated thoracic reirradiation for lung tumors. Lung Cancer 83:356–362

    Article  PubMed  Google Scholar 

  15. McAvoy SA, Ciura KT, Rineer JM et al (2013) Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol 109:38–44

    Article  Google Scholar 

  16. Ohguri T, Imada H, Yahara K et al (2012) Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients. Lung Cancer 77:140–145

    Article  PubMed  Google Scholar 

  17. Senthi S, van Sornsen de Koste JR, Griffioen GH, Slotman BJ, Senan S (2013) Comparing rigid and deformable dose registration for high dose thoracic re-irradiation. Radiother Oncol J Eur Soc Ther Radiol Oncol 106:323–326

    Article  Google Scholar 

  18. Evans JD, Gomez DR, Amini A et al (2013) Aortic dose constraints when reirradiating thoracic tumors. Radiother Oncol J Eur Soc Ther Radiol Oncol 106:327–332

    Article  Google Scholar 

  19. Feddock J, Arnold SM, Shelton BJ et al (2013) Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 85:1325–1331

    Article  PubMed  Google Scholar 

  20. Karam SD, Horne ZD, Hong RL, McRae D, Duhamel D, Nasr NM (2013) Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer. Radiat Oncol 8:179

    Article  PubMed Central  PubMed  Google Scholar 

  21. Grutters JP, Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P (2010) Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol J Eur Soc Ther Radiol Oncol 95:32–40

    Article  CAS  Google Scholar 

  22. Poltinnikov IM, Fallon K, Xiao Y, Reiff JE, Curran WJ Jr, Werner-Wasik M (2005) Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame. Int J Radiat Oncol Biol Phys 62:652–658

    Article  PubMed  Google Scholar 

  23. Kelly P, Balter PA, Rebueno N et al (2010) Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys 78:1387–1393

    Article  PubMed Central  PubMed  Google Scholar 

  24. Liu H, Zhang X, Vinogradskiy YY, Swisher SG, Komaki R, Chang JY (2012) Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Int J Radiat Oncol Biol Phys 84:1017–1023

    Article  PubMed Central  PubMed  Google Scholar 

  25. Parks J, Kloecker G, Woo S, Dunlap NE (2015) Stereotactic body radiation therapy as salvage for intrathoracic recurrence in patients with previously irradiated locally advanced non-small cell lung cancer. Am J Clin Oncol (in press)

  26. Reyngold M, Wu AJ, McLane A et al (2013) Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT). Radiat Oncol 8:99

    Article  PubMed Central  PubMed  Google Scholar 

  27. Trakul N, Harris JP, Le QT et al (2012) Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 7:1462–1465

    Google Scholar 

  28. Trovo M, Minatel E, Durofil E et al (2014) Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88:1114–1119

    Article  PubMed  Google Scholar 

  29. Seung SK SM. Salvage SBRT for previously irradiated lung cancer. J Canc Ther 2011:190–5

  30. Peulen H, Karlsson K, Lindberg K et al (2011) Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol 101:260–266

    Article  Google Scholar 

  31. Valakh V, Miyamoto C, Micaily B, Chan P, Neicu T, Li S (2013) Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site. J Cancer Res Ther 9:680–685

    Article  PubMed  Google Scholar 

  32. Hearn JVG, Djemil T, Stephans KL (2012) Salvage stereotactic body radiation therapy (SBRT) for local failure after upfront lung SBRT: if at first you don’t succeed. Int J Radiat Oncol Biol Phys 84:S602

    Article  Google Scholar 

  33. Sahgal A, Ma L, Weinberg V, et al (2012) Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol, Biol, phys 82:107–16.

  34. Lartigau EF, Tresch E, Thariat J, et al (2013) Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. Radiother Oncol: J of the Eur Soc for Ther Radiol and Oncol 109:281–5

  35. Rwigema JC, Heron DE, Ferris RL, et al (2010) Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience. Am J of Clinical Oncol 33:286–93

  36. Timmerman RD (2008) An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 18:215–22

  37. Kramer GW, Gans S, Ullmann E, van Meerbeeck JP, Legrand CC, Leer JW (2004) Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment? Int J Radiat Oncol Biol Phys 58:1388–1393

    Article  PubMed  Google Scholar 

  38. Cardona AF, Reveiz L, Ospina EG, Ospina V, Yepes A (2008) Palliative endobronchial brachytherapy for non-small cell lung cancer. Cochrane Database System Rev 12:CD004284

    Google Scholar 

  39. Ung YC, Yu E, Falkson C et al (2006) The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review. Brachytherapy 5:189–202

    Article  PubMed  Google Scholar 

  40. Guarnaschelli JN, Jose BO (2010) Palliative high-dose-rate endobronchial brachytherapy for recurrent carcinoma: the University of Louisville experience. J Palliat Med 13:981–989

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Andrew Vassil declares that he has no relevant conflicts of interest.

Gregory Videtic declares that he has no relevant conflicts of interest.

Kevin Stephans declares that he has no relevant conflicts of interest.

Ethical standards of data

This is a review paper and does not include primary patient data. All referenced works were approved by their respective institutional standards and ethics committees.

Informed consent

This is a review paper and does not include primary patient data.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Andrew D. Vassil, Gregory M. M. Videtic & Kevin L. Stephans

Authors
  1. Andrew D. Vassil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gregory M. M. Videtic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin L. Stephans
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin L. Stephans.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vassil, A.D., Videtic, G.M.M. & Stephans, K.L. Re-irradiation in lung cancer. J Radiat Oncol 4, 129–139 (2015). https://doi.org/10.1007/s13566-015-0190-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13566-015-0190-y

Keywords

Search

Navigation